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Abbreviations 
ELISA  Enzyme-linked immunosorbent assay 
ENS  Enteric nervous system 
HbA1C Glycated hemoglobin  
HO  Heme oxygenase 
HuC/D  Human neuronal protein 
GI  Gastrointestinal 
IL1  Interleukin 1 beta 
IL6  Interleukin 6 
IR   Immunoreactive  
nNOS  Neuronal nitric oxide synthase 
NO  Nitric oxide 
NOS  Nitric oxide synthase 
PB  Phosphate buffer 
STZ  Streptozotocin 
T1DM  Type 1 diabetes mellitus 
TBS   Tris-buffered saline 
TNFα  Tumor necrosis factor alpha 
 
 
 
1. Introduction 
The enteric nervous system (ENS) is the intrinsic nervous system of the gastrointestinal 
(GI) tract which is structurally organized into two major ganglionated plexuses: myenteric 
(Auerbach's) and submucous (Meissner's) plexus. Enteric neurons are responsible for the 
regulation of GI functions such as mucosal secretion, motility, blood flow, immune and 
inflammatory processes1. Therefore, any dysregulation in the ENS can lead to GI 
complications, like gastroparesis, motility disorders or delayed gastric emptying. 
It is reported that type 1 diabetes mellitus (T1DM) patients often suffer from GI motility 
abnormalities like nausea, vomiting, constipation and diarrhea2. The main underlying cause 
of these GI complications is the altered expression of nitric oxide synthase (NOS) in the 
gut. 
Nitric oxide (NO) plays a significant role as a non-adrenergic non-cholinergic 
neurotransmitter in regulating blood flow, sphincters, and motility of the gut. We have 
recently demonstrated that nitrergic myenteric neurons located in different intestinal 
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segments display different susceptibilities to diabetic damage. They also exhibit different 
levels of responsiveness to insulin treatment, which indicates the importance of the 
molecular difference in the neuronal microenvironment in the pathogenesis of diabetic 
nitrergic neuropathy3. We have also demonstrated that the mesenterial capillaries 
supplying the myenteric ganglia4 and the faecal-associated microbiota are also main targets 
of diabetic injuries5. 
Growing evidence indicates that long-lasting hyperglycaemia induces oxidative stress, 
decreases the effectiveness of the endogenous antioxidant protection and therefore plays a 
major role in the initiation of diabetes-related neuronal damage. Heme oxygenase (HO) is a 
rate limiting enzyme in the heme catabolism which produces biologically active carbon 
monoxide, iron and bilirubin. Three main HO isoforms, encoded by different genes, have 
been reported. These isoforms have different expression patterns mainly in tissues and 
cells. HO2, a constitutive enzyme, is highly expressed in neuronal tissues and acts as a 
critical mediator of cellular homeostasis, whereas HO1, a stress-inducible protein, 
expressed in relatively low level in most tissues6. The induction of HO1 have been 
reported to play a protective role against oxidative stress, ischaemia-reperfusion, hypoxia, 
reactive oxygen species and inflammation7. In addition, in rat ileum the antioxidant HO2 
protects those NOS-containing neurons in which it is co-localized from oxidative stress8. 
Due to the beneficial effects of the HO system, these endogenous antioxidants can be very 
important players in the prevention of oxidative injury and diabetic GI complications. 
Besides alterations of endogenous antioxidant system, the pro-inflammatory cytokines 
are also considered to be important cellular mediators in ENS pathology. It has been 
reported that the expression of pro-inflammatory cytokines such as tumor necrosis factor 
alpha (TNFα), interleukin 1 beta (IL1β) and interleukin 6 (IL6) are strongly upregulated in 
inflammatory as well as in neurological diseases9. Other than the deleterious effect to 
neurons, it has been reported that pro-inflammatory cytokines also act as neuroprotective 
agents in several disease conditions10. However, to date only few studies have reported the 
importance of HO system and pro-inflammatory cytokines in the enteric neurons in type 1 
diabetic rats. 
 
2. Aims 
HO system in the myenteric plexus 
- Is there any gut segment-specific difference in the number of myenteric HO1- and HO2-
IR neurons? 
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- Is there any effect of diabetes on the HO-nNOS colocalization in the myenteric plexus of 
the different intestinal segments? 
- Is there any effect of the diabetes on the serum and tissue level of HO1 and HO2? 
HO system in the submucous plexus 
- Is there any segment-specific effect of diabetes and immediate insulin treatment on the 
proportion of the nNOS-, HO1- and HO2-IR neurons? 
Pro-inflammatory cytokines 
- Is there any gut segment-specific difference in the expression of TNFα and IL6 in the 
myenteric ganglia and surrounding capillary endothelium of the control, diabetic and 
insulin-treated rats? 
- Is there any effect of the diabetes and insulin-treatment on the level of TNFα, IL1β and 
IL6 in tissue homogenates containing the myenteric or submucous plexus? 
 
3. Materials and methods 
In this study, we established a streptozotocin (STZ)-induced diabetic rat model which is 
suitable for investigating the effects of chronic hyperglycaemia and immediate insulin 
replacement in the ENS and its microenvironment along the GI tract. 
Animal model 
For the 10-week chronic hyperglycaemic study the rats were divided randomly into two 
groups: STZ-induced diabetics (n=6) and sex- and age-matched controls (n=10). Besides 
these two groups, for the investigation of the HO system in the submucous plexus and the 
expression of the pro-inflammatory cytokines, a third group, an insulin-treated diabetic 
group was also used (n=4)3. 
Blood collection and tissue handling 
Ten weeks after the onset of hyperglycaemia, the blood samples were collected for 
glycated haemoglobin (HbA1c) assay and enzyme-linked immunosorbent assay (ELISA). 
After the blood collection, the gut segments of the control, STZ-induced diabetic and 
insulin-treated diabetic rats were dissected and rinsed in 0.05 M phosphate buffer (PB, pH 
7.4). A 10 cm-long intestinal segments were taken from the duodenum (1 cm distal to the 
pylorus), the ileum (1 cm proximal to the ileo-caecal junction) and the proximal colon and 
were processed for immunohistochemical studies and ELISA. 
HbA1c assay 
Serum level of HbA1c was analysed by standard clinical chemistry assay on an 
Automated Chemistry Analyzer (BiOLis 24i, Tokyo Boeki Machinery Ltd, Tokyo, 
Japan)11. 
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Measurement of serum protein levels by ELISA 
Serum levels of HO1 and HO2 were measured by means of quantitative ELISA 
according to the manufacturer’s instructions (SunRed Biotechnology, Shanghai, China). 
Optical density was measured at 450nm (Benchmark Microplate Reader; Bio-Rad, 
Budapest, Hungary). The serum HO1 and HO2 concentrations were expressed as ng/ml. 
Double-labelling immunohistochemistry 
After fixation of the different gut segments in 4% paraformaldehyde solution, whole-
mounts from myenteric and submucous plexus were prepared and processed for the 
double-labelling immunohistochemistry. The samples were incubated overnight with 
primary antibodies (nNOS, HO1, HO2, HuC/D, peripherin) in various combinations. We 
used secondary antibodies (Alexa Fluor 488, Cy3) to evaluate the myenteric ganglia 
containing HO-immunoreactive (IR) and nNOS-HO-IR neurons and the submucous 
ganglia containing nNOS-IR, HO1-IR, and HO2-IR neurons under different experimental 
conditions. 
Postembedding immunohistochemistry 
Small pieces of the gut segments were fixed, embedded and processed for quantitative 
postembedding immunohistochemistry. Ultrathin sections from each block were 
preincubated in 1% bovine serum albumin, then in primary antisera (TNFα and IL6) 
overnight, followed by the species-specific secondary antibodies (anti-rabbit or anti-mouse 
IgG conjugated to 18 nm colloidal gold), with extensive washing in-between. Counting 
was performed on digital photographs of 5 myenteric ganglia and 5 mesenteric capillaries 
per intestinal segments in each experimental group at a magnification of 20000×. The total 
number of gold particles per unit area was counted in the entire profile of the myenteric 
ganglia and the endothelium of capillaries in the vicinity of the myenteric plexus with the 
ImageJ software (Wayne Rasband; National Institutes of Health, USA)4. 
Measurement of tissue HO1, HO2, TNFα, IL1β and IL6 concentrations 
Tissue homogenates from different intestinal segments containing the myenteric or 
submucous plexus were centrifuged at 5000 rpm for 20 min at 4 °C and used to determine 
the total protein content. Then the tissue total protein content was measured using the 
Bradford protein micromethod. Tissue homogenates obtained from the different intestinal 
segments were used to measure levels of HO1, HO2, TNFα, IL1β and IL6 by means of 
quantitative ELISA according to the manufacturer’s instructions (SunRed Biotechnology, 
Shanghai, China). Optical density was measured at 450 nm (Benchmark Microplate 
Reader; Bio-Rad, Budapest, Hungary). Tissue concentrations of HO1, HO2 were expressed 
as ng/mg protein, while TNFα, IL1β and IL6 were expressed as pg/mg protein. 
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Statistical Analysis 
Statistical analysis was performed with one-way ANOVA and the Newman–Keuls test. 
All analysis was carried out with GraphPad Prism 6.0 (GraphPad Software, La Jolla, CA, 
USA). A probability of P<0.05 was set as the level of significance. All data were expressed 
as mean ± SEM. 
 
4. Results 
Evaluation of HO-IR and nNOS-HO-IR neurons in myenteric ganglia  
In the controls, the number of HO-IR and nNOS-HO-IR myenteric neurons was the 
lowest in the ileal and the highest in the colonic segment. In diabetics, it increased the most 
extensively in the ileum and was also elevated in the colon. Although the total number of 
nitrergic neurons decreased in all the segments, the proportion of nNOS-IR neurons co-
localizing with HOs was enhanced robustly in the ileum and colon of diabetics. 
Evaluation of nNOS-IR, HO1-IR, and HO2-IR neurons in submucous ganglia  
The total number of submucous neurons and the proportion of nNOS-, HO1- and HO2-
IR subpopulations were not affected in the duodenal ganglia of control, diabetic and 
insulin-treated rats. While the total neuronal number did not change in either the ileum or 
the colon, the density of nitrergic neurons exhibited a 2- and 3-fold increase in the diabetic 
ileum and colon, respectively, which was further enhanced after insulin replacement.  
The proportion of HO1- and HO2-IR submucous neurons to the total number of 
submucous neurons was high in the colon of controls (38.4-50.8%), whereas it was 
significantly lower in the small intestinal segment (0.0-4.2%, P<0.0001). Under 
pathophysiological conditions the only alteration detected was an increase of the 
proportion of HO-IR neurons in the ileum and a decrease in the colon of insulin-treated 
diabetic rats. 
Intracellular distribution of TNFα and IL6 in the myenteric ganglia and capillary 
endothelium 
The number of TNFα- and IL6-labelling gold particles was strictly region-dependent in 
control animals with the numbers increasing to the distal direction. In diabetics, the 
number of TNFα-labelling gold particles was significantly increased in the duodenal, 
decreased in colonic myenteric ganglia while it did not show any significant difference in 
ileal ganglia. However, the number of IL6-labelling gold particles was not affected by 
diabetes in different gut regions. 
Regarding the capillary endothelium, the TNFα gold labelling was slightly altered in 
duodenal and colonic segments, however, significant increase was only observed in the 
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ileum of diabetic rats. In contrast, the density of IL6-labelling particles were not significant 
changed in capillary endothelium even under different experimental conditions. The 
diabetes-related alterations of TNFα- and IL6 expression were not protected by the 
immediate insulin replacement in any of the investigated intestinal segments. 
Tissue levels of pro-inflammatory cytokines in the smooth muscle layers and the 
myenteric plexus 
In tissue homogenates of control rats, the expression of TNFα, IL1β, and IL6 was 
strictly region-dependent. In the diabetic group, tissue levels of TNFα and IL1β were 
significantly increased only in the duodenum, whereas in the ileum and colon, levels were 
unaffected when compared to controls. The concentration of IL6 was decreased in the ileal 
segment, whereas it was unaltered in the duodenum and colon compared to controls. The 
immediate insulin treatment induced massive changes in TNFα and IL1β concentrations 
only in the duodenal segment, while IL6 concentrations were slightly elevated in the 
duodenum and decreased significantly in the ileum. 
Tissue levels of pro-inflammatory cytokines in the mucosa-submucous plexus 
In tissue homogenates of mucosa and submucosa including the submucous plexus of 
control rats, the expression of TNFα were strictly region-dependent. In diabetics, TNFα 
levels were significantly decreased in the ileum and colon, while in the duodenum it 
slightly, but not significantly increased when compared to controls. Interestingly, IL1β and 
IL6 were undetectable in the mucosa-submucosa of both control and diabetic groups. 
 
5. Discussion 
HO system in the myenteric plexus 
In support of our earlier finding that the susceptibility of nitrergic myenteric neurons to 
experimentally induced diabetes is strictly regional3, the present study provides evidence of 
gut segment-specific diabetes-related induction of the endogenous HO system and also 
intestinal region-dependent enhanced co-localization of HO1 and HO2 with nNOS in 
myenteric neurons. The occurrence of HO1- or HO2-containing myenteric ganglia, and the 
presence of those ganglia which include nNOS-HO1 or nNOS-HO2 co-localized neurons, 
was most pronounced in the colon and less represented in the ileum of control rats. 
Similarly, the number of HO1- or HO2- and nNOS-HO1- or nNOS-HO2-IR neurons was 
the highest in the colon and the lowest in the ileum under control conditions. Interestingly, 
in the control duodenum, although the number of HO1- or HO2- and nNOS-HO1- or 
nNOS-HO2-IR neurons was less than in the colon, still the presence of either HO-IR or 
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nNOS-HO-IR neurons representing myenteric ganglia was nearly as explicit as in the 
colon.  
In a previous study12 we demonstrated evidence that region-specific accumulation of 
reactive oxygen species leads to regionally distinct activation of antioxidant and apoptotic 
marker molecules in proximal and distal part of the gut in STZ-induced diabetic rats. This 
data also suggests that the distal part of the gut is more vulnerable to oxidative stress than 
the proximal. Therefore, we propose that in the colon, where the baseline oxidative 
environment is far from optimal, the basal expression of HOs as essential players of the 
endogenous defence mechanisms is the most pronounced. We suggest that in the ileum, the 
level of the HO proteins is extremely low in controls, which may result in much lower 
protection against different pathological stimuli. We also assume that as a result of the 
adequate oxidative environment and definite baseline expression of HOs and their co-
localization with nNOS in the myenteric ganglia in the proximal small intestine, the 
nitrergic neurons get greater protection and can tolerate hyperglycaemia-related oxidative 
stress better. Moreover, the highest levels of HO1 and HO2 expression in control 
duodenum tissue homogenates (including the smooth muscle layers of the gut wall and the 
myenteric plexus between them) also highlights an intensified protective environment in 
this particular gut segment and emphasizes the importance of the neuronal 
microenvironment3, 13.  
In diabetics, the number of HO1- or HO2-representing myenteric ganglia, as well as the 
number of those ganglia which contain nNOS-HO1 or nNOS-HO2 co-localized neurons 
were markedly elevated in the ileum. Likewise, the number of HO1- or HO2-IR and 
nNOS-HO1 or nNOS-HO2-IR neurons were altered in a region-dependent manner in 
diabetic rats. On the basis of our previous data, we suggest that the diabetes-related 
massive changes in the composition of the ileal gut microbiota5 may contribute to the 
enhanced mucosal immune response and the greatest induction of endogenous HO system 
in this particular gut segment. Accordingly, more nitrergic neurons started to produce HO 
enzymes. Moreover, this also means that those nNOS-positive neurons which are not 
expressing HOs will likely degenerate. Similar alterations were seen in the colon, from 
which we assume that HO-containing nitrergic neurons enjoy higher protection, whereas 
the others are heavily affected by diabetic damage. In the diabetic duodenum, besides a 
decreasing number of nNOS neurons, the number of co-localized myenteric neurons did 
not alter significantly, leading to the same conclusion. In summary, we propose that the 
reduced number of nNOS neurons means cell loss in the diabetic ileum and colon but a 
change in neurochemical character in the duodenum3,5.  
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HO system in the submucous plexus 
In the present study we demonstrate that the total submucous neuronal number is similar 
in the duodenum, ileum and colon in the controls, and remains unchanged in diabetes as 
well as after insulin replacement. This is in agreement with the observation of da Silva et 
al14, however their investigations are limited to the ileum. Our data reflect that STZ-
induced diabetes does not induce degenerative changes in the total population of 
submucous neurons, unlike our previous data about the myenteric plexus3. We suggest, in 
accordance with the opinion of Lopes et al15, that submucous neurons may have greater 
resistance to reactive oxygen and nitrogen species under diabetic conditions. Our results 
demonstrate that not only total neuronal density but also the nitrergic subpopulation of the 
two plexuses are affected differently by the diabetic state. An important finding of this 
study is that HO1- and HO2-IR neurons are more abundant in the colon than in the small 
intestinal segments in the controls and STZ treatment did not result in any significant 
changes in the investigated regions. It is possible that under worsening oxidative 
circumstances the pro-oxidant basal state in the colon acts as a preconditioning factor 
inducing the higher physiological activity of both isoforms of the antioxidant HO enzymes.  
We found no significant changes in the total number of submucous neurons of the three 
intestinal regions of insulin-treated diabetic rats. The density of nitrergic neurons showed 
similar patterns in the two plexuses after insulin replacement, an increase was found from 
proximal to distal direction, which means significant changes in the ileum and the colon as 
compared to untreated diabetic rats. As in the case of the nitrergic subpopulation, not the 
duodenal, but the ileal and colonic HO1- and HO2- IR submucous neurons responded to 
insulin treatment, but in an opposite way. However, there were no differences between the 
control and diabetic groups in these two regions and we found an increased density in the 
ileum, but a decreased abundance in the colon of insulin-treated diabetic rats. 
Our results suggest that the three investigated gut segments have different levels of 
responsiveness to immediate insulin replacement in diabetes regarding the nitrergic and 
HO-IR subpopulation of submucous neurons. This is confirmed by our earlier findings in 
the myenteric neurons and in their microenvironment including the capillary endothelium 
adjacent to the myenteric ganglia4. The environmental changes of myenteric ganglia were 
described, such as the alteration of the faeces-associated microbiota in diabetes and 
insulin-treatment5. On the other hand, our results are in accordance with the previous 
contradictory data about the beneficial or harmful effects of insulin3.  
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Distribution of TNFα- and IL6-labelling gold particles in the myenteric ganglia  
In this study, we quantified TNFα- and IL6-labelling gold particles in the myenteric 
ganglia and capillaries in their vicinity in control, diabetic and insulin-treated diabetic rats. 
We provide evidence that the distribution of these pro-inflammatory cytokines is strictly 
gut region-specific. The density of TNFα- and IL6-labelling gold particles was increased 
from proximal to the distal part of the GI tract of controls. Interestingly, the density of 
TNFα-labelling gold particles was significantly higher in the ganglia of diabetic and 
insulin-treated diabetic duodenum compared to the controls. This could explain that 
myenteric neurons express this cytokine at high levels in order to protect them from 
invading pathogenic microbes, thereby preventing tissue injury in this particular gut 
segments. Our result is correlated with Gonçalves et al.16 whose study reported that TNFα 
plays a significant role in controlling pathogenic bacterial populations and preventing 
tissue injury in the intestine of TNFRp55-/- mice. It has also been reported that expression 
of TNFα plays a dual role in T1DM, this study indicates that islet-specific TNFα 
expression abrogates the ongoing autoimmune process when induced late, but not in the 
early phase of T1DM pathogenesis17. 
The tissue levels of TNFα and IL1β (including the smooth muscle layers of the gut wall 
and the myenteric plexus between them) were increased significantly in tissue 
homogenates of the duodenum of diabetic and insulin-treated diabetic animals, while their 
levels did not change in the ileum and the colon. 
In the ileum, the density of TNFα-labelling gold particles was slightly increased, while 
in the colon it was significantly decreased in diabetics compared to the control group. It is 
in correlation with our previous results, we suggested that the colon was the only segment 
where the anti-apoptotic bcl-2 expression was increased and severe necrosis was also 
confirmed by electron microscopy in diabetic rats12. The density of TNFα-labelling gold 
particles was significantly decreased in the insulin-treated diabetics compared to the 
control group which indicates that immediate insulin treatment did not prevent the 
expressional changes of TNFα in the duodenum and colon. Interestingly, tissue levels of 
TNFα and IL1β were unaltered in the ileal and colonic myenteric plexus of different 
experimental groups, while the level of TNFα in submucous samples decreased 
significantly in the ileum and colon when compared to controls. Surprisingly, the density 
of IL6-labelling gold particles was unaffected by diabetes in the myenteric ganglia of 
duodenum, ileum, and colon. Our finding is in correlation with the results published by 
Hundhausen et al.18: IL6 expression was declined in the serum of patients with long-
standing T1DM, however, its expression was higher during the early stage of the disease. 
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The density of IL6 gold particles was significantly increased in the duodenum of 
insulin-treated diabetics compared to diabetics and the control group. This change is in line 
with our previous results, where immediate-insulin treatment prevented the diabetes-
related alteration of the microcirculation in the duodenum, but was not effective in the 
distal gut segments. 
In the ileum, the density of IL6-labelling gold particles in myenteric neurons remained 
at the same level in the diabetic and the insulin-treated diabetic group. In our previous 
study, we reported that the nitrergic subpopulation was reduced in the ileum of diabetic 
rats3. Taken together, we suggest that IL6 did not play any potential role in the myenteric 
neurons of the ileal segment. Similarly, in the colon, the density of IL6-labelling gold 
particles in the myenteric neurons slightly changed in diabetics when compared to control 
group. In contrast, in the insulin-treated diabetic group, IL6 expression was downregulated 
in the myenteric ganglia of the colon.  
Distribution of TNFα- and IL6-labelling gold particles in the capillary endothelium 
Similarly to our results in myenteric ganglia, the density of TNFα- and IL6-labelling 
gold particles in the endothelium showed segment-specific differences along the GI tract. 
The density of TNFα-labelling gold particles was slightly increased in the capillary 
endothelium of diabetic duodenum when compared to the controls. Several studies have 
reported that TNFα is a vascular permeability-increasing agent which activates number of 
cell adhesion molecules and chemoattractants19-22. However, in contrast to this notion, our 
previous results reported that the capillary basement membrane and vascular permeability 
were unaffected in the duodenum of diabetic rats4 and the present findings support that 
TNFα did not mediate capillary inflammation in the duodenum of diabetic rats. 
In the ileum, the number of TNFα gold particles was significantly increased in diabetics 
when compared to controls. This observation correlates well with our previous study, 
where structural, functional, and molecular alterations were observed in the capillary 
endothelium of ileal diabetic rats4, although the immediate-insulin treatment did not result 
in the change of the number of TNFα gold particles. In the colon, the number of TNFα 
gold particles remained at the same level in the capillary endothelium of the diabetics when 
compared to the control group. However, the immediate-insulin treatment decreased the 
density of TNFα gold particles in the colon, but did not reach the control level. In contrast, 
in our previous results, we demonstrated that capillary adjacent to the myenteric plexus 
was highly damaged in the colon of the diabetic rats. 
Taken together, the number of IL6-labelling gold particles was slightly increased in the 
capillary endothelium of duodenum, ileum, and colon of the diabetic rats. Interestingly, in 
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the insulin-treated diabetic group, IL6 expression was upregulated in the endothelium of 
duodenum. 
 
6. Conclusions 
The present study demonstrates evidence for intestinal region-specific diabetes-related 
alterations in the expression of endogenous HO enzymes and pro-inflammatory cytokines 
in enteric neurons and their microenvironment in experimental diabetes. We summarize 
our most important findings as follows: 
 We provide evidence for gut segment-specific diabetes-related induction of the 
endogenous HO system and also for intestinal region-dependent enhanced co-
localization of HO1 and HO2 with nNOS in myenteric neurons. We presume that those 
myenteric nitrergic neurons which do not co-localize with HOs are the most seriously 
affected by diabetic damage. 
 We demonstrate that the neurochemical character of nitrergic submucous neurons 
exhibit gut region-dependent changes in diabetic and insulin-treated diabetic rats. We 
show that HO1-IR and HO2-IR submucous neurons are present in small amounts in the 
small intestine, but in high abundance in the colon of control and diabetic rats, and they 
have segment-specific responsiveness to immediate insulin replacement. 
 The present study reveals a strictly gut-region dependent expression of TNFα and IL6 in 
the myenteric ganglia and supplying capillary endothelium of control, diabetic and 
insulin-treated diabetic rats. The density of TNFα and IL6-labelling gold particles is 
gradually decreasing from duodenum to colon in myenteric neurons of diabetic rats. The 
density of TNFα-labelling gold particles in the duodenal endothelium did not show 
significant differences in the different animal groups, while the density of IL6 was 
slightly elevated in diabetics, and significantly higher in the insulin-treated rats 
compared to controls. 
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